← Back to Search

Behavioral Intervention

Culturally tailored diabetes program for Type 2 Diabetes (Namaste Trial)

N/A
Waitlist Available
Led By Nadia A Khan, MD MSc
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months; 0, 3, and 6 months
Awards & highlights

Namaste Trial Summary

This trial will test whether a culturally tailored intervention can improve diabetes outcomes in South Asian patients.

Eligible Conditions
  • Type 2 Diabetes

Namaste Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months; 0, 3, and 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months; 0, 3, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in A1C or blood pressure (systolic or diastolic blood pressure)
Secondary outcome measures
Change in weight or waist circumference
change in fasting lipid profile
change in health status
Other outcome measures
Procedure related outcomes

Namaste Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Culturally tailored diabetes programExperimental Treatment1 Intervention
Culturally tailored diabetes program culturally tailored diabetes education lifestyle counselling medication adherence counseling peer supporter communication training family member involvement
Group II: Usual CareActive Control1 Intervention
Usual Care includes continuing to visit primary care physician for ongoing diabetes management Printed diabetes education materials.

Find a Location

Who is running the clinical trial?

Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,340 Previous Clinical Trials
26,452,098 Total Patients Enrolled
University of British ColumbiaLead Sponsor
1,413 Previous Clinical Trials
2,466,361 Total Patients Enrolled
Nadia A Khan, MD MScPrincipal InvestigatorUniversity of British Columbia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Novel Model for South Asian Treatment in Diabetes (NaMaSTe-Diabetes) Trial in Primary Care
Khan 2015. "Novel Model for South Asian Treatment in Diabetes (NaMaSTe-Diabetes) Trial in Primary Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02136654.
All > Gestational Diabetes
~62 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top